Financials
- Market Capitalization 149.8 M
- Employee 29
- Founded 2015
- CEO N/A
- Website nrxpharma.com
- Headquarter Delaware, United States
- FIGI BBG00JCWDN63
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-5.59
市销率
34.34
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3731 | INDP Indaptus Therapeutics, Inc. - Common Stock | 1.17 USD | +3.54% | +3.54% | -15.83% | -38.42% | 155.89 M USD | ||
| 3740 | OTLK Outlook Therapeutics, Inc. - Common Stock | 0.63 USD | +1.61% | -1.56% | -30.77% | +52.73% | 153.37 M USD | ||
| 3758 | MIST Milestone Pharmaceuticals Inc. - Common Shares | 1.18 USD | +3.51% | 0.00% | +4.42% | -33.71% | 146.91 M USD | ||
| 3764 | UNCY Unicycive Therapeutics, Inc. - Common Stock | 5.19 USD | +2.77% | -4.77% | +1.57% | -20.28% | 144.57 M USD |